FIELD: medicine.
SUBSTANCE: invention describes neuropeptide-2 receptor agonists of formula 
and also their pharmaceutically acceptable salts.
EFFECT: possibility of using the compounds for treating diseases, such as, eg obesity and diabetes.
11 cl, 25 dwg, 1 tbl, 44 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PEPTIDES HAVING AGONISTIC ACTIVITY ON NEUROPEPTIDE-2 RECEPTOR (Y2R) | 2006 |
|
RU2383553C2 |
| TRI-, TETRA-, PENTA- AND POLYPEPTIDES AND THEIR THERAPEUTIC USE AS ANTIDEPRESSANT AGENT | 1995 |
|
RU2182910C2 |
| METHOD (VERSIONS) AND PREPARATION FOR MODIFICATION OF EATING BEHAVIOUR | 2002 |
|
RU2519748C2 |
| SOMATOSTATIN RECEPTOR ANTAGONISTS | 1997 |
|
RU2179172C2 |
| PEPTIDES WITH AFFINITY FOR PARATHYROID HORMONE AND ACTIVITY- STIMULATING ADENYLCYCLASES | 1996 |
|
RU2157699C2 |
| GIP AGONIST COMPOUNDS AND METHODS | 2015 |
|
RU2716985C2 |
| ANTIBODY-STING AGONIST CONJUGATES AND USE THEREOF IN IMMUNOTHERAPY | 2020 |
|
RU2826228C2 |
| PRODRUG COMPOSITIONS WITH HIGH DEGREE OF PENETRATION BASED ON PEPTIDES AND RELATED COMPOUNDS | 2010 |
|
RU2627065C2 |
| CONJUGATE CONTAINING OXINTOMODULIN AND IMMUNOGLOBULIN FRAGMENT, AND ITS APPLICATION | 2012 |
|
RU2733544C2 |
| α-CYCLODEXTRIN-BASE PHARMACEUTICAL COMPOSITIONS FOR ORAL ADMINISTRATION OF ANALOGS OF RELEASING-HORMONE OF LUTEINIZING HORMONE (LH-RH) | 1999 |
|
RU2214270C2 |
